254 Results
Biodesix is making an oral presentation at SITC regarding a testing methodology that may identify primary immunotherapy resistance in patients
The Society for Advanced Bronchoscopy (SAB) will hold its second meeting: Hot Topics in Advanced Bronchoscopy.
Bronchoscopy professionals in the United States need greater educational and practice-building support to ensure continued delivery of high-quality care for Americans
New data demonstrate that a blood-based proteomic test reliably assesses individual patient prognosis to inform treatment decisions.
The study results indicate that the tests have the potential to offer clinically relevant information that could help physicians selecting immunotherapies for their patients make the best decision
Biodesix released data at ASCO-SITC on a new assay that measures PD-L1 in the blood of cancer patients.
Dr. Jeffrey Weber will present study results of new Biodesix immunotherapy test at ITOC4
Biodesix announced a biomarker research collaboration with Checkmate Pharmaceuticals, using Biodesix's proprietary discovery platform, the Diagnostic Cortex